Esperion Therapeutics Inc logo

Esperion Therapeutics Inc

$ 6.70 -0.14 (-2.05%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 445.90M
Enterprise V:
$ 520.22M
Volume:
1.71M
Avg Vol (2M):
1.23M
Also Trade In:
Volume:
1.71M
Market Cap $:
445.90M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.23M
Enterprise Value $:
520.22M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment.
Name Current Vs Industry Vs History
Cash-To-Debt 0.71
Equity-to-Asset -0.96
Debt-to-Equity -0.89
Debt-to-EBITDA -1.29
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.51
Distress
Grey
Safe
Beneish M-Score 330.14
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -0.7
3-Year EPS without NRI Growth Rate -7.3
3-Year FCF Growth Rate -18
Name Current Vs Industry Vs History
5-Day RSI 35.85
9-Day RSI 39.92
14-Day RSI 43.21
6-1 Month Momentum % 60.78
12-1 Month Momentum % -38.09

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.07
Quick Ratio 2.71
Cash Ratio 2.26
Days Inventory 425.43
Days Sales Outstanding 129.22
Days Payable 290.87

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -31.4

Financials (Next Earnings Date:2022-11-02 Est.)

ESPR's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ESPR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 67.487
EPS (TTM) ($) -6.37
Beta 0.1
Volatility % 70.06
14-Day RSI 43.21
14-Day ATR ($) 0.39923
20-Day SMA ($) 7.2165
12-1 Month Momentum % -38.09
52-Week Range ($) 3.28 - 12.15
Shares Outstanding (Mil) 66.55

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Esperion Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Esperion Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.